Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $11.9 $148,316 - $234,703
-19,723 Closed
0 $0
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $130,763 - $255,018
19,723 New
19,723 $139,000
Q3 2023

Oct 21, 2024

BUY
$6.05 - $9.28 $99,516 - $152,646
16,449 Added 104.77%
32,149 $194,000
Q3 2023

Nov 07, 2023

BUY
$6.05 - $9.28 $99,516 - $152,646
16,449 Added 104.77%
32,149 $194,000
Q2 2023

Oct 21, 2024

SELL
$4.95 - $8.4 $42,812 - $72,651
-8,649 Reduced 35.52%
15,700 $121,000
Q2 2023

Aug 07, 2023

SELL
$4.95 - $8.4 $42,812 - $72,651
-8,649 Reduced 35.52%
15,700 $121,000
Q1 2023

Oct 21, 2024

BUY
$4.26 - $6.75 $19,706 - $31,225
4,626 Added 23.45%
24,349 $138,000
Q1 2023

May 03, 2023

BUY
$4.26 - $6.75 $103,726 - $164,355
24,349 New
24,349 $138,000
Q2 2022

Aug 09, 2022

SELL
$2.7 - $7.07 $108,000 - $282,800
-40,000 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$4.54 - $16.1 $181,600 - $644,000
40,000 New
40,000 $213,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.